FACTORS CONTRIBUTING TO THE ACCELERATED CLEARANCE OF THEOPHYLLINE AND ANTIPYRINE IN ADULTS WITH EXOCRINE PANCREATIC DISEASE

被引:18
作者
ACHESON, DWK
HUNT, LP
ROSE, P
HOUSTON, JB
BRAGANZA, JM
机构
[1] MANCHESTER ROYAL INFIRM,DEPT GASTROENTEROL,OXFORD RD,MANCHESTER M13 9WL,LANCS,ENGLAND
[2] MANCHESTER ROYAL INFIRM,DEPT DIETET,MANCHESTER M13 9WL,LANCS,ENGLAND
[3] MANCHESTER ROYAL INFIRM,FAC MED,COMPUTAT GRP,MANCHESTER M13 9WL,LANCS,ENGLAND
[4] UNIV MANCHESTER,DEPT PHARM,MANCHESTER M13 9PL,LANCS,ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1042/cs0760377
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:377 / 385
页数:9
相关论文
共 39 条
[21]   EFFECTS OF DIETARY-PROTEIN ON THEOPHYLLINE PHARMACOKINETICS AND CAFFEINE AND AMINOPYRINE BREATH TESTS [J].
JUAN, D ;
WORWAG, EM ;
SCHOELLER, DA ;
KOTAKE, AN ;
HUGHES, RL ;
FREDERIKSEN, MC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (02) :187-194
[22]   ACUTE AND LATENT LEUKOPENIC REACTION TO ANTIPYRINE [J].
KADAR, D ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (06) :820-822
[23]   IMMUNOCHEMICAL EVIDENCE FOR INDUCTION OF THE ALCOHOL-OXIDIZING CYTOCHROME-P-450 OF RABBIT LIVER-MICROSOMES BY DIVERSE AGENTS - ETHANOL, IMIDAZOLE, TRICHLOROETHYLENE, ACETONE, PYRAZOLE, AND ISONIAZID [J].
KOOP, DR ;
CRUMP, BL ;
NORDBLOM, GD ;
COON, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (12) :4065-4069
[24]   MICROSOMAL ETHANOL-OXIDIZING SYSTEM [J].
LIEBER, CS .
ENZYME, 1987, 37 (1-2) :45-56
[25]   PHARMACOKINETICS OF THEOPHYLLINE IN HEPATIC DISEASE [J].
MANGIONE, A ;
IMHOFF, TE ;
LEE, RV ;
SHUM, LY ;
JUSKO, WJ .
CHEST, 1978, 73 (05) :616-622
[26]   A PRACTICAL GUIDE TO INTERACTIONS INVOLVING THEOPHYLLINE KINETICS [J].
MCELNAY, JC ;
SMITH, GD ;
HELLING, DK .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1982, 16 (7-8) :533-542
[27]   INFLUENCE OF METHYLXANTHINE-CONTAINING FOODS ON THEOPHYLLINE METABOLISM AND KINETICS [J].
MONKS, TJ ;
CALDWELL, J ;
SMITH, RL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) :513-524
[28]  
NIE, 1970, STATISTICAL PACKAGE
[29]  
OMALLEY K, 1972, CLIN PHARMACOL THER, V13, P552
[30]   CLINICAL IMPLICATIONS OF ENZYME-INDUCTION AND ENZYME-INHIBITION [J].
PARK, BK ;
BRECKENRIDGE, AM .
CLINICAL PHARMACOKINETICS, 1981, 6 (01) :1-24